William Lu
Impact in
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
Papers in
- Oncology 4
- Inflammatory Biomarkers in Disease Prognosis 2
- CAR-T cell therapy research 1
- Cancer Immunotherapy and Biomarkers 1
-
- Alzheimer's disease research and treatments 2
- Co-authors
- Basem N. Azab (2 shared papers)Scott W. Bloom (2 shared papers)Neeraj Nailesh Shah (2 shared papers)Nicolas R. Barthélemy (1 shared paper)Randall John Bateman (1 shared paper)Haiyan Liu (1 shared paper)Paul T. Kotzbauer (1 shared paper)Brendan P. Lucey (1 shared paper)
- Journals
- Nature (2 papers)JCO Precision Oncology (2 papers)Cancer Biomarkers (1 paper)Journal of Clinical Investigation (1 paper)Oncotarget (1 paper)
- Partner nations
- United StatesItalyGermany
In The Last Decade
William Lu
9 papers receiving 615 citations
William Lu's Hit Papers
Peers
Comparison fields: 5 of 52
- Oncology 374
- Immunology 132
- Psychiatry and Mental health 42
- Hepatology 17
- Physiology 46
Countries citing papers authored by William Lu
This map shows the geographic impact of William Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Lu more than expected).
Fields of papers citing papers by William Lu
This network shows the impact of papers produced by William Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Lu. The network helps show where William Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside William Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Non-viral precision T cell receptor replacement for personalized cell therapy Hit paper breakdown → | 2022 | 214 |
| 2 | 2023 | 128 | |
| 3 | 2013 | 125 | |
| 4 | 2020 | 105 | |
| 5 | 2014 | 50 | |
| 6 | 2018 | 5 | |
| 7 | 2018 | 4 | |
| 8 | 2025 | 1 | |
| 9 | 2025 | 1 |
About William Lu
William Lu is a scholar working on Oncology, Physiology, Biotechnology, Molecular Biology and Nuclear Energy and Engineering, having authored 9 papers that have together received 633 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (2 papers), Alzheimer's disease research and treatments (2 papers), Melanoma and MAPK Pathways (2 papers), Cancer Research and Treatments (1 paper), CAR-T cell therapy research (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Oncology (374 citations), Immunology (132 citations), Psychiatry and Mental health (42 citations), Hepatology (17 citations) and Physiology (46 citations). William Lu has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Basem N. Azab, Scott W. Bloom, Neeraj Nailesh Shah, Nicolas R. Barthélemy, Randall John Bateman, Haiyan Liu, Paul T. Kotzbauer, Brendan P. Lucey, Farhan Mohammed and Grant A. McArthur. Their work appears in journals such as Nature, JCO Precision Oncology, Cancer Biomarkers, Journal of Clinical Investigation and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.